Population Pharmacokinetics of Tafenoquine, a Novel Antimalarial-Reference-Cited by-同舟云学术

Population Pharmacokinetics of Tafenoquine, a Novel Antimalarial

Published:2018-11 Issue:11 Volume:62 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Thakkar Nilay¹^ORCID,Green Justin A.²,Koh Gavin C. K. W.²^ORCID,Duparc Stephan³^ORCID,Tenero David¹,Goyal Navin¹

Affiliation:

1. Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline Research and Development, King of Prussia, Pennsylvania, USA

2. GlaxoSmithKline Global Health Group, Stockley Park, Uxbridge, United Kingdom

3. Medicines for Malaria Venture, Geneva, Switzerland

Abstract

Tafenoquine is a novel 8-aminoquinoline antimalarial drug recently approved by the U.S. Food and Drug Administration (FDA) for the radical cure of acute Plasmodium vivax malaria, which is the first new treatment in almost 60 years.

Funder

Medicines for Malaria Venture

GlaxoSmithKline

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00711-18

Reference23 articles.

1. World Trade Report 2016

2. World Health Organization. Guidelines for the treatment of malaria. 2015. World Health Organization, Geneva, Switzerland.

3. Exposure-Response Analyses for Tafenoquine after Administration to Patients with Plasmodium vivax Malaria

4. Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial

5. Primaquine: the risks and the benefits

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Models of Tafenoquine: Insights for Optimal Malaria Treatment Strategies;Pharmaceutics;2024-08-26

2. Repurposing of the antimalarial agent tafenoquine to combat MRSA;mSystems;2023-12-21

3. Tafenoquine co-administered with dihydroartemisinin–piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study;The Lancet Infectious Diseases;2023-10

4. Practical Application of PK/TK Models: Population Pharmacokinetics/Toxicokinetics;Handbook of Pharmacokinetics and Toxicokinetics;2023-07-03

5. The Antimalarial Activity of Tafenoquine in Falciparum Malaria;Clinical Infectious Diseases;2023-02-16